Intellectual Property Magazine

Maura O'Malley

Document

Moderna loses bid to invalidate mRNA patents

Hannah Gannage-Stewart

The US Court of Appeals for the Federal Circuit has rejecteda bid by Moderna to invalidate two Arbutus Biopharma patents that may be relatedto its Covid-19 vaccine.

The rest of this document is only available to i-law.com online subscribers.

If you are already a subscriber, click Log In button.